Trial Details
COMPLETEDBasic Information
| Clinical ID | c1734 |
|---|---|
| Identifier | NCT05131971 |
| Trial Title | A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Multiple Sclerosis|Colitis, Ulcerative |
| Interventions | DRUG: GSK3888130B|DRUG: Placebo |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | Cambridge |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2021-11-01 |
|---|---|
| Primary Completion Date | 2023-10-12 |
| Completion Date | 2023-10-12 |